logo
Plus   Neg
Share
Email

Sarepta Therapeutics Q4 adjusted earnings Miss Estimates

Below are the earnings highlights for Sarepta Therapeutics (SRPT):

-Earnings: -$189.32 million in Q4 vs. -$235.70 million in the same period last year.
-EPS: -$2.40 in Q4 vs. -$3.16 in the same period last year.
-Excluding items, Sarepta Therapeutics reported adjusted earnings of -$145.10 million or -$1.84 per share for the period.
-Analysts projected -$1.77 per share
-Revenue: $145.14 million in Q4 vs. $100.11 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT